ENSAYO PARA LA DETECCIÓN DE LOS ANTICUERPOS TOTALES CONTRA EL ANTÍGENO NUCLEAR DE LA HEPATITIS B.
Mexico·Clase II·III. Agentes de
diagnóstico·SIEMENS HEALTHCARE
DIAGNOSTICS, S. DE R.L. DE
C.V.·Registered May 02, 2024- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- ATELLICA® IM HBC TOTAL 2 (HBCT2).
- Trade Name (English)
- ATELLICA® IM HBC TOTAL 2 (HBCT2).
- Analysis ID
- 1268R2024 SSA
- Registration Date
- May 02, 2024
- Name (Spanish)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.
- Name (English)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.
Access comprehensive regulatory information for ENSAYO PARA LA DETECCIÓN DE LOS ANTICUERPOS TOTALES CONTRA EL ANTÍGENO NUCLEAR DE LA HEPATITIS B. (ENSAYO PARA LA DETECCIÓN DE LOS ANTICUERPOS TOTALES CONTRA EL ANTÍGENO NUCLEAR DE LA HEPATITIS B.) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1268R2024 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.. The device was registered on May 02, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.